EVE JOHNSON: Open Payments
NPI 1215453006 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,231 in 82 payments from 30 companies in 2025. Trend: 2023 $264 · 2024 $2,877 · 2025 $2,231
Food & beverage: $2,039Education: $192
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $353 |
| Daiichi Sankyo Inc. | 5 | $292 |
| Pharmacosmos Therapeutics Inc. | 1 | $112 |
| E.R. Squibb & Sons, L.L.C. | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| PharmaEssentia USA Corporation | 3 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| Celgene Corporation | 3 | $85 |
| Incyte Corporation | 3 | $76 |
Products named: ERLEADA, Enhertu, DATROWAY, TECVAYLI, COSELA, REBLOZYL, BESREMI, Nubeqa.
Industry payments across TX — which companies pay providers there.
